Raphael Pharmaceutical
$1.5100
0
+$0.11+7.86%Friday 13:30
Statistics
Day High
1.51
Day Low
1.51
52W High
1.51
52W Low
0.4
Volume
100
Avg. Volume
1
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Show More
CEO
Shlomo Pilo
Country
Israel
ISIN
US27785B2088
Listings
0 Comments
Share your thoughts
FAQs
What is Raphael Pharmaceutical stock price today?▼
The current price of RAPH is $1.51 USD — it has increased by +7.86% in the past 24 hours. Watch Raphael Pharmaceutical stock price performance more closely on the chart.
What is Raphael Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Raphael Pharmaceutical stocks are traded under the ticker RAPH.
Is Raphael Pharmaceutical stock price growing?▼
RAPH stock has risen by +0% compared to the previous week, the month change is a +7.86% rise, over the last year Raphael Pharmaceutical has showed a +51% increase.
In which sector is Raphael Pharmaceutical located?▼
Raphael Pharmaceutical operates in the Health & Wellness sector.
When did Raphael Pharmaceutical complete a stock split?▼
Raphael Pharmaceutical has not had any recent stock splits.
Where is Raphael Pharmaceutical headquartered?▼
Raphael Pharmaceutical is headquartered in Jaffa, Israel.